Yan Hou Selected Research

botrocetin

1/2021

In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIbα.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Hou Research Topics

Disease

27	Neoplasms (Cancer) 03/2022 - 04/2006
10	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 02/2015
8	Ovarian Epithelial Carcinoma 01/2020 - 08/2011
6	Inflammation (Inflammations) 01/2022 - 09/2009
5	Thrombosis (Thrombus) 10/2021 - 02/2014
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 01/2011
4	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2011
4	Infections 10/2020 - 12/2009
3	Carcinoma (Carcinomatosis) 01/2019 - 08/2011
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 04/2021
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2021
2	Enteritis 09/2021 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2021 - 05/2021
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 05/2021 - 04/2006
2	Neuroblastoma 04/2021 - 01/2009
2	Lymphatic Metastasis 04/2021 - 01/2018
2	Leiomyoma (Uterine Fibroids) 01/2021 - 04/2016
2	Hypersensitivity (Allergy) 01/2021 - 01/2016
2	Pre-Eclampsia (Preeclampsia) 01/2021 - 03/2019
2	COVID-19 10/2020 - 10/2020
2	Stroke (Strokes) 01/2020 - 04/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022
1	Rupture 05/2022
1	Allergic Rhinitis 01/2022
1	Rhinitis 01/2022
1	Cognitive Dysfunction 01/2022
1	Abdominal Obesity 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Osteoporosis 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Syphilis 10/2021
1	Sepsis (Septicemia) 07/2021
1	Acute Lung Injury 07/2021

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2011
7	LipidsIBA 01/2022 - 06/2009
7	Proteins (Proteins, Gene)FDA Link 05/2021 - 04/2006
5	Pharmaceutical PreparationsIBA 03/2022 - 11/2008
5	Long Noncoding RNAIBA 04/2021 - 01/2017
4	Therapeutic UsesIBA 01/2022 - 02/2006
4	Biological ProductsIBA 01/2020 - 01/2017
3	Small Interfering RNA (siRNA)IBA 01/2022 - 04/2010
3	TeaIBA 09/2021 - 06/2009
2	LipopolysaccharidesIBA 01/2022 - 07/2021
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2022 - 04/2016
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022 - 04/2016
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2021
2	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 09/2009
2	Circular RNAIBA 09/2021 - 05/2021
2	AntioxidantsIBA 07/2021 - 06/2009
2	Messenger RNA (mRNA)IBA 05/2021 - 01/2017
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2019
2	AntigensIBA 01/2021 - 05/2008
2	SurvivinIBA 01/2021 - 04/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2013
2	Agkistrodon acutus agkisacucetin proteinIBA 01/2021 - 02/2014
2	riamilovirIBA 10/2020 - 10/2020
2	Antiviral Agents (Antivirals)IBA 10/2020 - 06/2008
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	LigandsIBA 11/2018 - 12/2016
2	LactamsIBA 03/2016 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2016 - 01/2016
1	Drinking WaterIBA 06/2022
1	NGR peptideIBA 03/2022
1	Matrix Metalloproteinases (MMPs)IBA 03/2022
1	Anti-Allergic Agents (Antiallergic Agents)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2022
1	HDL CholesterolIBA 01/2022
1	Inulin FDA Link 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	AcidsIBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 12/2021
1	AfatinibIBA 12/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2021
1	HMGB1 Protein (HMG1)IBA 07/2021
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 07/2021
1	InflammasomesIBA 07/2021
1	LuciferasesIBA 05/2021
1	Untranslated RNA (Noncoding RNA)IBA 04/2021
1	Nanoparticle Drug Delivery SystemIBA 01/2021
1	CollagenIBA 01/2021
1	botrocetinIBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 02/2006
4	Drug Therapy (Chemotherapy) 03/2022 - 01/2013
3	Immunotherapy 01/2022 - 01/2018
3	Neoadjuvant Therapy 01/2017 - 01/2011
2	Radiotherapy 05/2022 - 01/2013
2	Lasers (Laser) 01/2022 - 02/2014
1	Intravenous Administration 03/2022
1	Acupuncture Therapy 01/2022
1	Ovariectomy (Oophorectomy) 01/2022
1	Thrombectomy 10/2021
1	Ligation 07/2021
1	Punctures 07/2021